| Date Filed | Type | Description |
| 06/16/2023 |
4
| Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 01/05/2023 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 22,300 shares
@ $0
Sold 1,639 shares
@ $5.5756, valued at
$9.1k
Sold 729 shares
@ $5.4075, valued at
$3.9k
Granted 44,600 options to buy
@ $5.73, valued at
$255.6k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 2,000 options to buy
@ $4.17, valued at
$8.3k
Exercised 333 options to buy
@ $3.72, valued at
$1.2k
|
|
| 01/05/2022 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 12,000 shares
@ $0
Sold 1,445 shares
@ $10.6115, valued at
$15.3k
Granted 53,000 options to buy
@ $10.69, valued at
$566.6k
|
|
| 07/15/2021 |
4
| Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 25,000 options to buy
@ $17.88, valued at
$447k
|
|
| 07/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $21.08, valued at
$1.7M
|
|
| 01/24/2020 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 1,000 options to buy
@ $3.72, valued at
$3.7k
|
|
| 07/19/2019 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 2,000 options to buy
@ $3.72, valued at
$7.4k
|
|
| 05/10/2019 |
4
| Moses Jennifer K. (CFO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $20.91, valued at
$1M
|
|
| 01/17/2019 |
4
| Moses Jennifer K. (VP of Finance) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 2,000 options to buy
@ $3.72, valued at
$7.4k
|
|
| 01/02/2019 |
4
| Moses Jennifer K. (VP of Finance) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $19.56, valued at
$391.2k
|
|
| 12/07/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $34, valued at
$25.5k
Exercised 750 options to buy
@ $0.39, valued at
$292.5
Exercised 2,000 options to buy
@ $3.72, valued at
$7.4k
|
|
| 11/07/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $41.38, valued at
$31k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $59.6, valued at
$44.7k
Exercised 2,000 options to buy
@ $3.72, valued at
$7.4k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 08/06/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $50.79, valued at
$38.1k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 07/05/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $45.66, valued at
$34.2k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 06/05/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $38.77, valued at
$29.1k
Exercised 250 options to buy
@ $0.39, valued at
$97.5
Exercised 500 options to buy
@ $0.39, valued at
$195 |
|
| 05/07/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $45, valued at
$33.8k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 04/05/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $37.47, valued at
$28.1k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 03/06/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $26.55, valued at
$19.9k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 02/06/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $22.99, valued at
$17.2k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 01/08/2018 |
4
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 750 shares
@ $19.96, valued at
$15k
Exercised 750 options to buy
@ $0.39, valued at
$292.5 |
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2017 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities [Amend] |
| 05/16/2017 |
3
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 3 on G1 Therapeutics, Inc. |